Ramachandran Murali
- Oncology top 2%
- HER2/EGFR in Cancer Research 21
- Bone health and treatments 11
- Virology top 2%
- HIV Research and Treatment 11
- Immunology top 5%
- Molecular Biology top 2%
- Glycosylation and Glycoproteins Research 16
- Bone Metabolism and Diseases 14
- Chemical Synthesis and Analysis 10
-
- Monoclonal and Polyclonal Antibodies Research 39
-
- NF-κB Signaling Pathways 11
- Co-authors
- Alan BerezovHongtao ZhangMark I. GreeneQiang WangJeffrey A. DrebinGeng ZhangThomas Kieber‐EmmonsRoger M. Burnett
- Cited by
- OncologyVirologyImmunology
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (8 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Ramachandran Murali
158 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 157
- Oncology 1.5k
- Virology 240
- Immunology 909
- Molecular Biology 2.7k
- Radiology, Nuclear Medicine and Imaging 830
Countries citing papers authored by Ramachandran Murali
This map shows the geographic impact of Ramachandran Murali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramachandran Murali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramachandran Murali more than expected).
Fields of papers citing papers by Ramachandran Murali
This network shows the impact of papers produced by Ramachandran Murali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramachandran Murali. The network helps show where Ramachandran Murali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ramachandran Murali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 28 | |
| 7 | 2022 | 27 | |
| 8 | Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth | 2021 | 1 |
| 9 | 2021 | 29 | |
| 10 | 2021 | 16 | |
| 11 | 2018 | 17 | |
| 12 | 2018 | 18 | |
| 13 | 2017 | 49 | |
| 14 | Modelling photosynthetic rates of Indian red mangroves (Rhizophora mucronata Poir.) to climatic factors. | 2017 | 1 |
| 15 | 2017 | 29 | |
| 16 | 2015 | 282 | |
| 17 | AUTOPHAGY IS THE EMERGING ROLE IN PLANT DEFENSE AGAINST PATHOGEN ATTACK | 2012 | 3 |
| 18 | 2006 | 17 | |
| 19 | 2005 | 38 | |
| 20 | Antibody like peptidomimetics as large scale immunodetection probes. | 2003 | 3 |
About Ramachandran Murali
Ramachandran Murali is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 163 papers that have together received 5.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (39 papers), HER2/EGFR in Cancer Research (21 papers), Glycosylation and Glycoproteins Research (16 papers), Bone Metabolism and Diseases (14 papers), HIV Research and Treatment (11 papers), Bone health and treatments (11 papers), NF-κB Signaling Pathways (11 papers) and Chemical Synthesis and Analysis (10 papers). The work is most often cited by research in Oncology (1.5k citations), Virology (240 citations) and Immunology (909 citations). Ramachandran Murali has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Alan Berezov, Hongtao Zhang, Mark I. Greene, Mark I. Greene, Qiang Wang, Jeffrey A. Drebin, Geng Zhang, Thomas Kieber‐Emmons, Roger M. Burnett and Stephen J. Pandol. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.